« back to directory
Company Profile
Proteolytics Pty Ltd
About Proteolytics Pty Ltd
Proteolytics Pty Ltd, based in Perth, is developing and commercialising OPAL-A, a proprietary botanical extract from paw paw fruit to treat hard-to-heal wounds for human and animal health. A 2nd-generation candidate, PL-001, combines OPAL-A with Proteolytics’ novel technology for enhancing and stabilising enzymatic activity, ProteoActiv™.
Proteolytics’ approach is to target hard-to-heal wounds:
- where current debridement and wound-healing treatments are proving ineffective;
- which are of greatest concern to the international medical community;
- where enzymatic agents have shown activity in the clinical setting; and
- where the ProteoActiv™ technology could improve efficacy by enhancing and stabilising enzymatic activity